Choose Your language:
- Testimonials
-
Bon matin:
V générique est vraiment comme je m'y attendais, même mieux, et le prix est aussi normal. Ne vous inquétez pas !
Merci bien pour votre aide
Veillez agréer, Steve
En savoir plus »
Notre page de facturation est certifiée par:
-
- Somaxon and CJ CheilJedang Announce Silenor(R) Collaboration in South Korea - MarketWatch (press release)
- Somaxon and CJ CheilJedang Announce Silenor(R) Collaboration in South KoreaMarketWatch (press release)Silenor is a low-dose (3 mg and 6 mg) oral tablet formulation of doxepin, and is the first and only non-scheduled prescription sleep medication approved to treat insomnia characterized by difficulties with sleep maintenance
- Somaxon and CJ CheilJedang Announce Silenor® Collaboration in South Korea - SunHerald.com
- SunHerald
- Infinite Itch: Learning to Live With Hives - New York Times (blog)
- New York Times (blog)Infinite Itch: Learning to Live With HivesNew York Times (blog)But doxepin, the drug that finally suppressed the hives, made him so sleepy that he repeatedly dozed off on a desk during six weeks of job training
- Infinite itch: Learning to live with hives - Sarasota Herald-Tribune
- Sarasota Herald-TribuneInfinite itch: Learning to live with hivesSarasota Herald-TribuneBut doxepin, the drug that finally suppressed the hives, made him so sleepy that he repeatedly dozed off on a desk during six weeks of job training
- Somaxon, CJ CheilJedang sign Silenor commercialization agreement - Pharmaceutical Business Review
- Somaxon, CJ CheilJedang sign Silenor commercialization agreementPharmaceutical Business ReviewSomaxon Pharmaceuticals and CJ CheilJedang have signed a commercialization agreement in South Korea for Silenor (doxepin) to treat insomnia
